The current stock price of IDXX is 639.6 USD. In the past month the price decreased by -4.54%. In the past year, price increased by 39.11%.
ChartMill assigns a technical rating of 2 / 10 to IDXX. When comparing the yearly performance of all stocks, IDXX is one of the better performing stocks in the market, outperforming 75.21% of all stocks.
ChartMill assigns a fundamental rating of 7 / 10 to IDXX. IDXX scores excellent points on both the profitability and health parts. This is a solid base for a good stock.
Over the last trailing twelve months IDXX reported a non-GAAP Earnings per Share(EPS) of 13.07. The EPS increased by 16.18% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 24.65% | ||
| ROA | 30.34% | ||
| ROE | 65.81% | ||
| Debt/Equity | 0.53 |
22 analysts have analysed IDXX and the average price target is 783.52 USD. This implies a price increase of 22.5% is expected in the next year compared to the current price of 639.6.
For the next year, analysts expect an EPS growth of 13.15% and a revenue growth 8.72% for IDXX
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 21.24 | 190.25B | ||
| ISRG | INTUITIVE SURGICAL INC | 55.62 | 176.09B | ||
| SYK | STRYKER CORP | 27.01 | 140.78B | ||
| BSX | BOSTON SCIENTIFIC CORP | 31.14 | 136.19B | ||
| BDX | BECTON DICKINSON AND CO | 14 | 57.63B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.16 | 47.96B | ||
| RMD | RESMED INC | 24.78 | 37.18B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 17.45 | 36.49B | ||
| DXCM | DEXCOM INC | 38.99 | 28.29B | ||
| PODD | INSULET CORP | 56.15 | 18.05B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.66 | 17.09B | ||
| HOLX | HOLOGIC INC | 17.46 | 16.66B |
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 11,000 full-time employees. The firm also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.
IDEXX LABORATORIES INC
One Idexx Drive
Westbrook MAINE 04092 US
CEO: Jonathan J. Mazelsky
Employees: 11000
Phone: 12075560300
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 11,000 full-time employees. The firm also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. The Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. The LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, and to improve the quality and safety of milk.
The current stock price of IDXX is 639.6 USD. The price decreased by -4.6% in the last trading session.
IDXX does not pay a dividend.
IDXX has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
22 analysts have analysed IDXX and the average price target is 783.52 USD. This implies a price increase of 22.5% is expected in the next year compared to the current price of 639.6.
The PE ratio for IDEXX LABORATORIES INC (IDXX) is 48.94. This is based on the reported non-GAAP earnings per share of 13.07 and the current share price of 639.6 USD.